| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.9B | $19.6B | $18.8B | $20.8B | $18.5B | $4.2B | $2.6B | $2.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $8.9B | $5.9B | $5.1B | $7.2B | $5.9B | $1.1B | $0.9B | $0.9B |
| EPS (Basic) | $4.67 | $3.00 | $2.55 | $3.52 | $2.84 | $0.57 | $0.62 | $0.66 |
| EPS (Diluted) | $4.65 | $2.99 | $2.54 | $3.50 | $2.83 | $0.57 | $0.62 | $0.65 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $491.0B | $479.8B | $493.2B | $551.8B | $667.3B | $549.0B | $294.0B | $296.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $46.0B | $42.1B | $43.3B | $40.2B | $63.0B | $40.3B | $29.3B | $27.9B |
| Total Liabilities | $441.6B | $431.5B | $452.2B | $515.2B | $611.0B | $492.9B | $272.3B | $275.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $49.4B | $48.4B | $41.0B | $36.6B | $56.3B | $56.1B | $21.7B | $20.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.3B | $2.7B | $19.6B | $2.1B | $2.1B | $6.9B | $9.3B | $12.5B |
| Investing Cash Flow | $24.5B | $35.4B | $57.4B | $32.0B | $-75.7B | $-125.9B | $12.0B | $-40.6B |
| Capital Expenditures | $0.5B | $0.6B | $0.7B | $1.0B | $0.9B | $0.6B | $0.7B | $0.6B |
| Financing Cash Flow | $-29.7B | $-47.1B | $-61.2B | $-68.7B | $96.3B | $144.0B | $-13.9B | $47.2B |